It is likely that these adverse changes in mesangial cells, endothelial cells, and podocytes may be interrelated, and hyperglycemia is also known to disrupt the podocyte–glucocorticoid receptor signaling pathway to trigger EndMT and cause glomerular fibrosis in DM. This evidence concerns the gene NR3C1 and diabetes mellitus.